Marsh & McLennan (NYSE:MMC) maintains global leadership in risk, insurance, and consulting within the S&P 500 ETF.

Discusses Innovations in Inhaled Treprostinil Therapies and Updates on Drug Delivery Technologies October 28, 2025 2:00 ...